Skip to main content
. 2019 May 1;36(2):157–166. doi: 10.36141/svdld.v36i2.7636

Fig. 1.

Fig. 1.

Overall survival following first application of cyclophosphamide [days] stratified for ANCA-associated vasculitis (i.e. GPA, MPA), GPS, DM, SSc and other ILD forms (Log Rank p=0.040).

Legend: SSc: Systemic sclerosis, n=1; ANCA-ass vasculitis: Anti-neutrophil cytoplasmic antibodies-associated vasculitis (i.e. Granulomatosis with polyangiitis (GPA), Microscopic polyangiitis (MPA) and Eosinophilic granulomatosis with polyangiitis (EGPA)), n=7; GPS: Goodpasture syndrome, n=2; DM: Dermatomyositis, n=2; others, n=2, containing COP: Cryptogen organizing pneumonia, and DRESS: Drug reaction with eosinophilia and systemic symptoms. Survival axis scale [days] is split (indicated by //) after 140 days and then shows greater intersections.